Lexicon Pharmaceuticals to Host 2024 Investor Day [Yahoo! Finance]
Lexicon Pharmaceuticals, Inc. (LXRX)
Last lexicon pharmaceuticals, inc. earnings: 4/27 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
lexpharma.com/investors
Company Research
Source: Yahoo! Finance
THE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024. The event will be held in New York City from 9:00 a.m. to 12:00 p.m. ET. Business and scientific updates will be presented by Lonnel Coats, Lexicon's chief executive officer; Jeff Wade, Lexicon's president and chief financial officer; Alan Main, Ph.D., Lexicon's executive vice president, innovation and chemical sciences; Tom Garner, Lexicon's senior vice president and chief commercial officer; and Craig Granowitz, M.D., Ph.D., Lexicon's senior vice president and chief medical officer. The corporate presentations and panel discussion with renowned medical leaders will highlight Lexicon's strategy and efforts to address major areas of need in: Heart Failure Diabetic Peripheral Neuropathic Pain Hypertrophic Cardiomyopathy Type 1 Diabetes O
Show less
Read more
Impact Snapshot
Event Time:
LXRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LXRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LXRX alerts
High impacting Lexicon Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
LXRX
News
- Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $5.00 price target on the stock.MarketBeat
- Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals [Yahoo! Finance]Yahoo! Finance
- Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon PharmaceuticalsGlobeNewswire
- Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 2, 2024GlobeNewswire
LXRX
Earnings
- 3/11/24 - Beat
LXRX
Sec Filings
- 4/29/24 - Form 4
- 4/29/24 - Form 4
- 4/29/24 - Form 4
- LXRX's page on the SEC website